NCT00405886View on ClinicalTrials.gov

Neramexane for Tinnitus

PHASE2CompletedINTERVENTIONAL
Enrollment

431

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions
Tinnitus
Interventions
DRUG

Neramexane

Oral tablets, duration: 16 weeks

DRUG

Placebo

Oral tablets, duration: 16 weeks

Trial Locations (2)

Unknown

Vienna

Munich

Sponsors
All Listed Sponsors
lead

Merz Pharmaceuticals GmbH

INDUSTRY

NCT00405886 - Neramexane for Tinnitus | Biotech Hunter | Biotech Hunter